| My Account | Subscribe | Contact Us | Donate |
Home
- The Edmonton Protocol and Me
- Olympia Dukakis and Her Husband Tackle Type 2
- Surfing with Type 1
- Behind the Wheel, But Still in Control
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Other Lab Tests Articles
As a result, the beta cells regenerated and were able to begin producing insulin - essentially reversing the diabetes.
They've Done it in Mice... Now They Plan to Cure Type 1 in Humans
Researchers at Children’s Hospital in Pittsburgh have started an FDA-approved phase 1 test in humans of a lab procedure that successfully reversed type 1 diabetes in mice.
In the original procedure, scientists extracted dendritic cells from the blood of a diabetic mouse. Dendritic cells are immune cells that identify foreign substances and spur infection-fighting T cells to defend the body. Recent research has shown that in mice with diabetes, dendritic cells mistake islet cells in the pancreas for foreign invaders, then wrongly incite attacks upon them—proof of the autoimmune nature of type 1 diabetes.
The scientists “enhanced” the extracted cells with “blockers” that inhibit T cell response, then injected the treated cells back into the mouse. Over several weeks, the beefed-up dendritic cells were able to completely shut off the T cell attacks on the pancreatic beta cells. As a result, the beta cells regenerated and were able to begin producing insulin—essentially reversing the diabetes.
Insulin Will Assist Dendritic Cell “Targeting”
The phase 1 trial, which began in March, involves 15 type 1 patients over 18 years of age. The trial team is led by Dr. Massimo Trucco, the Hillman Professor of Pediatric Immunology at Children’s Hospital and a professor of Pediatrics at the University of Pittsburgh School of Medicine.
Dr. Trucco and his team want to combine the dendritic cells with small portions of insulin, in the hope that the insulin will guide the dendritic cells directly to the T cells. Adding the insulin will ensure that the dendritic cells specifically block T cell destruction of the beta cells and do not otherwise interrupt the immune system.
Categories: Other Lab Tests, Type 1 Issues
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
May 30, 2008 -
Email to a Friend
Send a link to this page to your friends and colleagues.